CA Stock MarketDetailed Quotes

BIOV BioVaxys Technology Corp

Watchlist
  • 0.060
  • -0.005-7.69%
15min DelayTrading Jul 17 09:46 ET
13.21MMarket Cap-1500P/E (TTM)

BioVaxys Technology Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.62%-436.93K
100.75%2.38K
33.01%-1.05M
99.03%-2.02K
68.67%-23.74K
15.69%-711.83K
28.79%-317.25K
70.26%-1.57M
72.51%-209.02K
96.48%-75.79K
Net income from continuing operations
63.58%-542.39K
154.19%518.05K
34.45%-7.69M
57.10%-3.67M
-72.71%-1.58M
-40.84%-1.49M
21.07%-956.05K
-81.60%-11.73M
-239.19%-8.55M
-0.78%-912.17K
Operating gains losses
----
----
-192.68%-229.95K
---218.08K
--12.58K
-271.54%-36.03K
117.34%11.57K
4,282.02%248.11K
----
----
Asset impairment expenditure
----
----
-80.46%1.45M
-106.94%-513.03K
--1.01M
----
----
--7.4M
--7.4M
--0
Remuneration paid in stock
-74.69%11.78K
-65.40%22.46K
-69.87%150.63K
-102.69%-4.52K
-45.25%43.71K
-47.41%46.53K
-60.33%64.91K
-56.04%499.97K
-46.90%168.01K
-44.27%79.84K
Other non cashItems
----
-12,767.42%-880.39K
2,852.78%3.08M
11,608.43%3.05M
-112.74%-3.34K
65.49%26.8K
-80.60%6.95K
0.27%104.23K
8.67%26.03K
-16.66%26.19K
Change In working capital
145.57%94.52K
-38.37%342.26K
14.99%2.19M
171.31%1.35M
-32.77%488.08K
-275.70%-207.43K
-1.00%555.37K
2,383.94%1.9M
-64.72%498.69K
151.08%725.98K
-Change in receivables
-533.98%-39.05K
64.70%-12.72K
-1,250.79%-42.23K
-1.62%-8.08K
-200.61%-7.11K
240.22%9K
-428.45%-36.04K
668.99%3.67K
-777.51%-7.95K
120.67%7.07K
-Change in prepaid assets
244.29%130.48K
56.22%-189.22K
42.53%-121.47K
181.52%198.1K
465.66%203.1K
-617.30%-90.43K
-5,273.45%-432.24K
-147.79%-211.36K
-118.27%-243.02K
102.72%35.9K
-Change in payables and accrued expense
102.46%3.1K
-46.84%544.2K
11.43%2.35M
55.14%1.16M
-57.23%292.1K
-191.91%-126K
88.99%1.02M
502.21%2.11M
811.51%749.66K
1,154.52%683K
Cash from discontinued investing activities
Operating cash flow
38.62%-436.93K
100.75%2.38K
33.01%-1.05M
99.03%-2.02K
68.67%-23.74K
15.69%-711.83K
28.79%-317.25K
70.26%-1.57M
72.51%-209.02K
96.48%-75.79K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
2.68%687.94K
289.59%962.67K
-17.25%917.1K
0
0
-14.06%670K
247.1K
-67.77%1.11M
-45.85%328.6K
0
Net common stock issuance
7.67%721.37K
289.59%962.67K
-17.25%917.1K
--0
--0
-14.06%670K
--247.1K
-63.79%1.11M
-32.11%328.6K
--0
Cash from discontinued financing activities
Financing cash flow
2.68%687.94K
289.59%962.67K
-17.25%917.1K
--0
--0
-14.06%670K
--247.1K
-67.77%1.11M
-45.85%328.6K
--0
Net cash flow
Beginning cash position
1,247.71%965.14K
-99.31%977
-76.08%141.9K
-98.92%423
-74.92%28.48K
-51.94%71.61K
-76.08%141.9K
-75.52%593.12K
-94.73%39.05K
-91.77%113.57K
Current changes in cash
-1,825.12%-805.35K
1,475.68%965.05K
70.46%-137.75K
-101.69%-2.02K
68.67%-23.74K
35.30%-41.83K
84.25%-70.15K
74.87%-466.36K
177.93%119.58K
88.20%-75.79K
Effect of exchange rate changes
96.77%-42
-565.67%-892
-120.95%-3.17K
115.39%2.58K
-439.87%-4.31K
-104.45%-1.3K
-109.75%-134
-40.51%15.15K
-385.16%-16.73K
-54.50%1.27K
End cash Position
460.92%159.74K
1,247.71%965.14K
-99.31%977
-99.31%977
-98.92%423
-74.92%28.48K
-51.94%71.61K
-76.08%141.9K
-76.08%141.9K
-94.73%39.05K
Free cash from
-109.78%-1.49M
100.75%2.38K
33.01%-1.05M
99.03%-2.02K
68.67%-23.74K
15.69%-711.83K
28.79%-317.25K
70.26%-1.57M
72.51%-209.02K
96.48%-75.79K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.62%-436.93K100.75%2.38K33.01%-1.05M99.03%-2.02K68.67%-23.74K15.69%-711.83K28.79%-317.25K70.26%-1.57M72.51%-209.02K96.48%-75.79K
Net income from continuing operations 63.58%-542.39K154.19%518.05K34.45%-7.69M57.10%-3.67M-72.71%-1.58M-40.84%-1.49M21.07%-956.05K-81.60%-11.73M-239.19%-8.55M-0.78%-912.17K
Operating gains losses ---------192.68%-229.95K---218.08K--12.58K-271.54%-36.03K117.34%11.57K4,282.02%248.11K--------
Asset impairment expenditure ---------80.46%1.45M-106.94%-513.03K--1.01M----------7.4M--7.4M--0
Remuneration paid in stock -74.69%11.78K-65.40%22.46K-69.87%150.63K-102.69%-4.52K-45.25%43.71K-47.41%46.53K-60.33%64.91K-56.04%499.97K-46.90%168.01K-44.27%79.84K
Other non cashItems -----12,767.42%-880.39K2,852.78%3.08M11,608.43%3.05M-112.74%-3.34K65.49%26.8K-80.60%6.95K0.27%104.23K8.67%26.03K-16.66%26.19K
Change In working capital 145.57%94.52K-38.37%342.26K14.99%2.19M171.31%1.35M-32.77%488.08K-275.70%-207.43K-1.00%555.37K2,383.94%1.9M-64.72%498.69K151.08%725.98K
-Change in receivables -533.98%-39.05K64.70%-12.72K-1,250.79%-42.23K-1.62%-8.08K-200.61%-7.11K240.22%9K-428.45%-36.04K668.99%3.67K-777.51%-7.95K120.67%7.07K
-Change in prepaid assets 244.29%130.48K56.22%-189.22K42.53%-121.47K181.52%198.1K465.66%203.1K-617.30%-90.43K-5,273.45%-432.24K-147.79%-211.36K-118.27%-243.02K102.72%35.9K
-Change in payables and accrued expense 102.46%3.1K-46.84%544.2K11.43%2.35M55.14%1.16M-57.23%292.1K-191.91%-126K88.99%1.02M502.21%2.11M811.51%749.66K1,154.52%683K
Cash from discontinued investing activities
Operating cash flow 38.62%-436.93K100.75%2.38K33.01%-1.05M99.03%-2.02K68.67%-23.74K15.69%-711.83K28.79%-317.25K70.26%-1.57M72.51%-209.02K96.48%-75.79K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 2.68%687.94K289.59%962.67K-17.25%917.1K00-14.06%670K247.1K-67.77%1.11M-45.85%328.6K0
Net common stock issuance 7.67%721.37K289.59%962.67K-17.25%917.1K--0--0-14.06%670K--247.1K-63.79%1.11M-32.11%328.6K--0
Cash from discontinued financing activities
Financing cash flow 2.68%687.94K289.59%962.67K-17.25%917.1K--0--0-14.06%670K--247.1K-67.77%1.11M-45.85%328.6K--0
Net cash flow
Beginning cash position 1,247.71%965.14K-99.31%977-76.08%141.9K-98.92%423-74.92%28.48K-51.94%71.61K-76.08%141.9K-75.52%593.12K-94.73%39.05K-91.77%113.57K
Current changes in cash -1,825.12%-805.35K1,475.68%965.05K70.46%-137.75K-101.69%-2.02K68.67%-23.74K35.30%-41.83K84.25%-70.15K74.87%-466.36K177.93%119.58K88.20%-75.79K
Effect of exchange rate changes 96.77%-42-565.67%-892-120.95%-3.17K115.39%2.58K-439.87%-4.31K-104.45%-1.3K-109.75%-134-40.51%15.15K-385.16%-16.73K-54.50%1.27K
End cash Position 460.92%159.74K1,247.71%965.14K-99.31%977-99.31%977-98.92%423-74.92%28.48K-51.94%71.61K-76.08%141.9K-76.08%141.9K-94.73%39.05K
Free cash from -109.78%-1.49M100.75%2.38K33.01%-1.05M99.03%-2.02K68.67%-23.74K15.69%-711.83K28.79%-317.25K70.26%-1.57M72.51%-209.02K96.48%-75.79K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg